Plant-Based Meat and Cardiovascular Disease: A Promising Avenue with Research Gaps to Address

The growing popularity of plant-based meat alternatives (PBMAs) stems from a confluence of health, environmental, and ethical concerns. While their long-term health effects are under ongoing investigation, a growing body of evidence suggests PBMAs may offer a cardioprotective benefit. This holds particular significance considering the well-established link between red and processed meat consumption and an increased risk of CVD, the leading cause of global mortality.

PBMAs and Improved CVD Risk Factors: Emerging Evidence

Comparative studies evaluating PBMAs against meat consumption have yielded promising results. Substituting meat with PBMAs has been associated with favorable changes in key CVD risk factors:

  • Reduced Low-Density Lipoprotein Cholesterol (LDL-C): LDL-C, often referred to as “bad” cholesterol, plays a critical role in atherogenesis, the buildup of plaque in arteries. Several studies, including the SWAP-MEAT trial, have observed reductions in LDL-C levels among participants who transitioned from meat to PBMAs. The SWAP-MEAT trial specifically found that consuming PBMAs for 8 weeks resulted in a 2.0 μmol/L lower LDL-C concentration compared to organic grass-fed meat products.

  • Potential Weight Management: While not all studies have shown a significant impact on weight, some research suggests PBMAs may contribute to weight loss, another established factor influencing CVD risk. One potential mechanism is that PBMAs may be more satiating than meat due to their higher fiber content, leading to reduced overall calorie intake.

  • Neutral Blood Pressure Impact: Despite concerns regarding sodium content in some PBMAs, current research has not demonstrated a negative impact on blood pressure. For example, the SWAP-MEAT trial found no significant differences in blood pressure measurements between participants consuming PBMAs and those consuming meat, even though the PBMAs used were high in sodium. This suggests other factors in the PBMAs, or dietary adjustments made by participants, may have counterbalanced the potential blood pressure-raising effect of sodium.

These findings are encouraging; however, it is important to acknowledge that many of the studies involved short-term interventions. Further long-term research is necessary to confirm if these improvements in CVD risk factors translate into a reduced risk of actual CVD events such as myocardial infarction (heart attack) and stroke. Additionally, future studies should investigate potential mechanisms by which PBMAs might exert their effects, such as influencing gut microbiota composition or modifying inflammatory markers.

Nutritional Profile of PBMAs and Potential CVD Benefits

Compared to their meat counterparts, PBMAs generally boast a nutritional profile that may be more conducive to cardiovascular health:

  • Lower Saturated Fat (SFA) Content: SFA is a primary driver of LDL-C elevation. PBMAs tend to be lower in SFA content compared to meat. For instance, the Beyond Meat pea protein-based PBMAs used in the SWAP-MEAT trial were entirely free of cholesterol, unlike the meat products.

  • Higher Dietary Fiber: Fiber promotes a reduction in cholesterol and fosters overall gut health, which can indirectly benefit cardiovascular well-being. Fiber intake may also contribute to feelings of satiety, potentially aiding in weight management efforts.

  • Diverse Plant-Based Protein Sources: PBMAs often incorporate protein sources like soy, pea, and mycoprotein. These may offer additional benefits, such as soy isoflavones, which have been linked to a lower CVD risk. Studies suggest that isolated pea protein, used in some PBMAs, may also improve CVD risk factors although more research is needed to confirm these findings.

Uncertainties and Future Research Directions

While the initial research on PBMAs and CVD is promising, knowledge gaps remain that require further exploration:

  • Impact of Varied PBMA Ingredients: More research is needed to delineate the specific effects of various protein sources and processing methods on CVD risk. For example, some PBMAs rely heavily on coconut oil, which is high in SFA. While it may still lower LDL-C compared to butter, it is not ideal for cardiovascular health. Conversely, PBMAs formulated with canola oil, rich in unsaturated fats, are likely to have a more favorable impact on cholesterol levels.

  • Long-Term CVD Event Outcomes: Long-term studies are crucial to determine if the observed improvements in risk factors translate into a lower risk of actual CVD events. This will provide more definitive evidence regarding the potential role of PBMAs in CVD prevention strategies.

  • Sodium Content and Blood Pressure Management: While current research has not shown a negative impact on blood pressure, further studies are warranted, particularly for individuals with hypertension. Additionally, research could explore the development of PBMAs with lower sodium content while maintaining a desirable taste and texture.

  • Overall Diet Context: The health benefits of PBMAs are likely maximized when incorporated into a balanced, plant-based diet rich in fruits, vegetables, whole grains, and legumes. Conversely, consuming PBMAs alongside a diet high in processed foods and refined carbohydrates may diminish their potential CVD benefits.

  • Processing Methods and Ingredient Quality: The processing techniques used in PBMA production can influence their nutritional profile and potential health effects. Studies are needed to explore the impact of different processing methods on factors like the formation of advanced glycation end products (AGEs) and the overall digestibility of the product. Additionally, investigating the quality of ingredients used in PBMAs is crucial. For example, using whole food sources for protein and fiber may offer greater health advantages compared to highly refined ingredients.

  • Role of Gut Microbiota: Emerging research suggests a link between gut microbiota composition and CVD risk. Since PBMAs can alter gut microbiota, future studies could investigate how specific PBMA formulations might influence gut bacteria in a way that promotes cardiovascular health.

  • Sustainability Considerations: While PBMAs generally have a lower environmental footprint compared to meat production, the sustainability of specific ingredients and processing methods varies. Research is needed to identify the most environmentally sustainable PBMA production practices.


PBMAs represent a promising avenue for promoting cardiovascular health. Their lower SFA content, higher fiber content, and potential for incorporating heart-healthy plant proteins position them as potentially valuable substitutes for meat in the diet. However, further research is needed to address knowledge gaps regarding the long-term effects of PBMAs on CVD events, the impact of specific ingredients and processing methods on health outcomes, and the role of PBMAs within the context of a broader dietary pattern. By addressing these research questions, we can gain a more comprehensive understanding of the potential role of PBMAs in promoting cardiovascular health and creating sustainable dietary practices.

Posted June 2024.

Subscribe to our newsletter

Personalised by your preferences, subscribe to our newsletters to get the best of the Pharmaceutical Industry news in your inbox.

Take Your Pharma Career Further. Explore Specialized Courses.